scholarly article | Q13442814 |
P356 | DOI | 10.1007/S11095-011-0524-4 |
P698 | PubMed publication ID | 21735335 |
P2093 | author name string | Ying Zhang | |
Kris Hansen | |||
Ken Brown | |||
Kris Siebenaler | |||
Amy Determan | |||
Daniel Dohmeier | |||
P2860 | cites work | Dermal and underlying tissue pharmacokinetics of lidocaine after topical application. | Q51631818 |
Topical glyceryl trinitrate and eutectic mixture of local anaesthetics in children. A randomised controlled trial on choice of site and ease of venous cannulation. | Q51704698 | ||
Adjunctive use of hyaluronidase in local anaesthesia. | Q51802278 | ||
Pain-free venepuncture. Effect of timing of application of local anaesthetic cream. | Q51838455 | ||
Factors affecting plasma levels of lignocaine and prilocaine | Q52733036 | ||
Lidocaine toxicity | Q28369125 | ||
NMR characterisation and transdermal drug delivery potential of microemulsion systems | Q30620441 | ||
Effect of epinephrine on lidocaine clearance in vivo: a microdialysis study in humans | Q30790387 | ||
Topical anesthetics update: EMLA and beyond | Q30814366 | ||
Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin | Q33805053 | ||
Transdermal drug delivery | Q37238479 | ||
Current status and future prospects of transdermal drug delivery. | Q40918936 | ||
Microneedle pretreatment improves efficacy of cutaneous topical anesthesia | Q43160498 | ||
Dermal pharmacokinetics of microemulsion formulations determined by in vivo microdialysis | Q43665634 | ||
Transdermal delivery of desmopressin using a coated microneedle array patch system | Q44948638 | ||
Microneedle mediated delivery of nanoparticles into human skin. | Q47331967 | ||
Influence of volume on the spread of local anesthetic-methylene blue solution after injection for intercostal block | Q50790290 | ||
Effects of vasoconstriction on dermal pharmacokinetics and local tissue distribution of compounds. | Q51631813 | ||
P433 | issue | 1 | |
P921 | main subject | lidocaine | Q216935 |
P304 | page(s) | 170-177 | |
P577 | publication date | 2011-07-07 | |
P1433 | published in | Pharmaceutical Research | Q7180737 |
P1476 | title | Development of lidocaine-coated microneedle product for rapid, safe, and prolonged local analgesic action | |
P478 | volume | 29 |
Q86952621 | A drug-laden elastomer for surgical treatment of anal fistula |
Q36490572 | A facile system to evaluate in vitro drug release from dissolving microneedle arrays |
Q35778613 | A simple and high-resolution HPLC-PDA method for simultaneous quantification of local anesthetics in in vitro buccal permeation enhancement studies. |
Q47255436 | Accelerating Topical Anaesthesia Using Microneedles |
Q51830991 | Acceptability of microneedle-patch vaccines: A qualitative analysis of the opinions of parents. |
Q39162365 | Analgesic Microneedle Patch for Neuropathic Pain Therapy. |
Q38630763 | Biomedical applications of microneedles in therapeutics: recent advancements and implications in drug delivery. |
Q36196224 | Bleomycin-Coated Microneedles for Treatment of Warts |
Q35219316 | Coating solid dispersions on microneedles via a molten dip-coating method: development and in vitro evaluation for transdermal delivery of a water-insoluble drug |
Q38860500 | Considerations in the use of microneedles: pain, convenience, anxiety and safety |
Q37468550 | Controlled Drug Delivery Using Microdevices |
Q91778005 | Design rules for a tunable merged-tip microneedle |
Q47995144 | Dissolving microneedles to obtain rapid local anesthetic effect of lidocaine at skin tissue |
Q47344337 | Drug-coated microneedles for rapid and painless local anesthesia |
Q90318630 | Effect of dosing regimen and microneedle pretreatment on in vitro skin retention of topically applied beta-blockers |
Q47977602 | Effects of eight vehicles on transdermal lidocaine penetration in sheep skin in vitro |
Q47569582 | Efficacy of a bleomycin microneedle patch for the treatment of warts |
Q41518982 | Enhanced delivery of hydrophilic peptides in vitro by transdermal microneedle pretreatment |
Q57291851 | In Vitro Skin Retention and Drug Permeation through Intact and Microneedle Pretreated Skin after Application of Propranolol Loaded Microemulsions |
Q89287740 | Individually coated microneedles for co-delivery of multiple compounds with different properties |
Q45760750 | Influenza subunit vaccine coated microneedle patches elicit comparable immune responses to intramuscular injection in guinea pigs |
Q47290157 | Large Size Microneedle Patch to Deliver Lidocaine through Skin. |
Q47717700 | Lidocaine permeation from a lidocaine NaCMC/gel microgel formulation in microneedle-pierced skin: vertical (depth averaged) and horizontal permeation profiles |
Q47629261 | Local, Controlled Delivery of Local Anesthetics In Vivo from Polymer - Xerogel Composites |
Q38105616 | Microarrays and microneedle arrays for delivery of peptides, proteins, vaccines and other applications |
Q41006286 | Microfabrication for Drug Delivery |
Q38646712 | Microneedle patches for vaccination in developing countries. |
Q30575700 | Microneedle patches: usability and acceptability for self-vaccination against influenza |
Q38680038 | Microneedle technology for immunisation: Perception, acceptability and suitability for paediatric use. |
Q35563011 | Microneedle-Mediated Delivery of Copper Peptide Through Skin. |
Q47952817 | Microneedle-assisted permeation of lidocaine carboxymethylcellulose with gelatine co-polymer hydrogel |
Q28085656 | Microneedle-based drug and vaccine delivery via nanoporous microneedle arrays |
Q36164749 | Microneedles for drug and vaccine delivery |
Q30472037 | New delivery systems for local anaesthetics-part 2. |
Q38122744 | Novel engineered systems for oral, mucosal and transdermal drug delivery. |
Q38108243 | Potential of biodegradable microneedles as a transdermal delivery vehicle for lidocaine |
Q47666014 | Recent advances of controlled drug delivery using microfluidic platforms. |
Q64892919 | Recent advances of microneedles for biomedical applications: drug delivery and beyond. |
Q33832173 | The effects of chemical and physical penetration enhancers on the percutaneous permeation of lidocaine through equine skin |
Q26778469 | Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum |
Search more.